Davis Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
BCWM
SMDAM
Davis Capital Management's AMGN Position: Q2 2026 in Review
Davis Capital Management reduced its Amgen (AMGN) stake by 1.2% in Q2 2026, selling an estimated $26K and leaving 6,521 shares worth $2.36M. The position accounts for 1.4% of the portfolio, ranked #21.
Davis Capital Management first reported a position in AMGN in Q1 2020 and has held it in 12 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Davis Capital Management held 6,521 shares of Amgen worth $2.36M as of Q2 2026.
- Davis Capital Management sold 76 Amgen shares in Q2 2026, an estimated $26K.
- Amgen made up 1.4% of Davis Capital Management's portfolio in Q2 2026, its #21 holding.
- Davis Capital Management first reported a position in Amgen in Q1 2020 and has held it in 12 quarters since.
- 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.